Researchers led by the Icahn School of Medicine at Mount Sinai focused on proteinases, enzymes that break down proteins as part of cellular life.
Matrix metalloproteinases or MMPs specifically target the extracellular matrix, the non-cell, structural framework within tissues.
Beyond that role, the new study found that one member of this family, MMP-2, has another signalling role related to the human immune system.
It may shift a set of cells to become part of immune response that accelerates healing in some cases, but may worsen inflammatory disease in others.
Also Read
"Our results show that MMP-2 uses a multitude of mechanisms to modulate the immune system," said the study's lead investigator Nina Bhardwaj, Director of Immunotherapy, Tisch Cancer Center at Mount Sinai, Professor of Medicine, Hematology and Oncology, Icahn School of Medicine at Mount Sinai.
"These data provides context to how this mechanism happens and could lead to novel treatments," Bhardwaj said.
The study was published in the journal Cell Reports.